The FDA is considering barring laboratory developed testing for Lyme disease. This means that testing such as the urine LDA/PCR test through IgeneX won't be available anymore because it isn't compliant with the IDSA two tier testing approach of an ELISA and then a Western blot. Here is an article from Lyme Policy that has [...]
